Study type

Study type

Non-interventional study

Scope of the study

Assessment of risk minimisation measure implementation or effectiveness
Drug utilisation
Effectiveness study (incl. comparative)
Study drug and medical condition

Name of medicine, other

Alvalin

Medical condition to be studied

Obesity
Population studied

Age groups

Adults (18 to < 46 years)
Adults (46 to < 65 years)
Adults (65 to < 75 years)
Adults (75 to < 85 years)
Adults (85 years and over)

Estimated number of subjects

1000
Study design details

Main study objective

Untersuchung der Sicherheit von Alvalin® unter den Bedingungen des Praxisalltags.Evaluation of safety of Alvalin for use in everyday practice.

Outcomes

Erfassung von Art und Häufigkeit von Beschwerden.Collecting of kind and frequency of adverse events. Erfassung von Daten zur Dosierung, der Einnahmedauer, der Unterbrechung (inklusive der Gründe) und der Wirksamkeit unter Praxisbedingungen.Collecting data concerning dosage, duration of intake, interruption of treatment (with reasons) and efficacy for use in everyday practice.

Data analysis plan

- in progress -